Skip to main content
ConductScienceScienceDex

ScienceDex / Researcher record

Geballe, Adam P.

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #19,291
Unclaimed recordClaim profile
  • R01 Holder
  • Long-Funded

NIH Funding · FY2023

Linked Award Amount
$623.3K
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#19,291
By linked amount among FY2023 PIs
Earliest Year Loaded
2001
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2001$519,6262#8,101
2002$173,0001#24,498
2003$387,4251#13,463
2004$383,4001#14,314
2005$387,4251#14,430
2011$479,7881#15,997
2012$523,6662#15,050
2013$514,6341#14,492
2014$477,0701#16,014
2015$489,2961#15,913
2019$689,0441#13,613
2021$635,9931#16,975
2022$629,1641#18,188
2023$623,2961#19,291

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20012 records
  2. FY20021 record
  3. FY20031 record
  4. FY20041 record
  5. FY20051 record
  6. FY20111 record
  7. FY20122 records
  8. FY20131 record
  9. FY20141 record
  10. FY20151 record
  11. FY20191 record
  12. FY20211 record
  13. FY20221 record
  14. FY2023 · selected1 record

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Geballe, Adam P.. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2023 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2001 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2023 award categories

  • Pediatrics

FY2023 award records by amount

NIH award records listing Geballe, Adam P. as a PI. Multi-PI records show the full award amount for context.

  • 5R01HD098866-05R01Contact PI
    Optimizing Immunity and Maternal Host Defense Against Congenital Cytomegalovirus Infection
    University of Minnesota · Pediatrics (NIH department code)
    $623.3K
    award amount

Award organization

Organizations that administered FY2023 awards listing Geballe, Adam P. as a PI.

FY2023 award administered by University of Minnesota (MN).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2001
    First NIH Award
    University of Minnesota
  2. 2001
    $500K Cumulative Funding
  3. 2001
    Entered Top 50% Nationally
    Ranked #8101
  4. 2003
    $1M Cumulative Funding
  5. 2005
    R01 Grant Holder
  6. 2011
    $2M Cumulative Funding
  7. 2019
    $5M Cumulative Funding

Explore further

Find collaborators for Geballe, Adam P.

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →